Scientific News Eli Lilly Chief Scientist Daniel M Skovronsky Beware Elected Leaders Who Would Weaken Patents
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Eli Lilly Chief Scientist Daniel M Skovronsky Beware Elected Leaders Who Would Weaken Patents is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Lilly’s head scientist discusses its GLP-1 pill, Alzheimer’s strategy, and finding promising ideas and startups
In San Diego for the opening of Lilly's latest Gateway Labs biotech incubator, CSO Daniel Skovronsky spoke broadly about the company’s R&D plans ... Read More
Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure
Eli Lilly and Co on Tuesday aimed to ease investor concerns about its COVID-19 antibody treatment after a trial of the therapy failed to show a benefit in hospitalized patients. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus